|
| | HR0563 | | LRB103 35665 LAW 65740 r |
|
|
| 1 | | HOUSE RESOLUTION
|
| 2 | | WHEREAS, Variants of the SCN2A gene are the leading |
| 3 | | single-gene cause of neurodevelopmental disorders such as |
| 4 | | autism, childhood seizures, and intellectual disabilities; and
|
| 5 | | WHEREAS, SCN2A disorders are also associated with a |
| 6 | | spectrum of syndromes ranging from severe, life-threatening |
| 7 | | conditions to developmental delays, including sleep |
| 8 | | disturbances, gastrointestinal dysfunctions, movement |
| 9 | | disorders, pain, and dysautonomia; and
|
| 10 | | WHEREAS, Research predicts that approximately one in 9,000 |
| 11 | | people will be diagnosed with SCN2A-related disorders; and
|
| 12 | | WHEREAS, While SCN2A-related disorders can be easily |
| 13 | | identified by DNA testing, SCN2A-related disorders frequently |
| 14 | | go undetected due to a lack of awareness, even within the |
| 15 | | medical community; and
|
| 16 | | WHEREAS, The field of study of SCN2A-related disorders is |
| 17 | | growing, but additional studies are needed to develop |
| 18 | | therapies and treatments; and
|
| 19 | | WHEREAS, International SCN2A Awareness Day is held |
| 20 | | annually on February 24th; therefore, be it
|